vs
Side-by-side financial comparison of Neptune Insurance Holdings Inc. (NP) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $37.8M, roughly 1.7× Neptune Insurance Holdings Inc.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 0.1%, a 39.3% gap on every dollar of revenue.
Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
NP vs SLNO — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.8M | $66.0M |
| Net Profit | $50.0K | $26.0M |
| Gross Margin | — | 98.3% |
| Operating Margin | — | 33.5% |
| Net Margin | 0.1% | 39.4% |
| Revenue YoY | 28.8% | — |
| Net Profit YoY | 0.0% | 134.0% |
| EPS (diluted) | $0.05 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $37.8M | — | ||
| Q3 25 | $44.4M | $66.0M | ||
| Q2 25 | — | $32.7M | ||
| Q3 24 | $33.8M | — |
| Q1 26 | $50.0K | — | ||
| Q3 25 | $11.5M | $26.0M | ||
| Q2 25 | — | $-4.7M | ||
| Q3 24 | $12.1M | — |
| Q1 26 | — | — | ||
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | 46.7% | 33.5% | ||
| Q2 25 | — | -20.0% | ||
| Q3 24 | 58.6% | — |
| Q1 26 | 0.1% | — | ||
| Q3 25 | 25.9% | 39.4% | ||
| Q2 25 | — | -14.4% | ||
| Q3 24 | 35.8% | — |
| Q1 26 | $0.05 | — | ||
| Q3 25 | $0.06 | $0.47 | ||
| Q2 25 | — | $-0.09 | ||
| Q3 24 | $0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $494.8M |
| Total Assets | — | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q3 25 | $12.2M | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | $247.6M | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | $-509.5M | $494.8M | ||
| Q2 25 | — | $240.1M | ||
| Q3 24 | $-374.3M | — |
| Q1 26 | — | — | ||
| Q3 25 | $89.6M | $599.9M | ||
| Q2 25 | — | $332.3M | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $43.5M |
| Free Cash FlowOCF − Capex | — | $43.5M |
| FCF MarginFCF / Revenue | — | 65.8% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q3 25 | $38.9M | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | 3.38× | 1.67× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
